Rapid benefits of a new formulation of subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis

被引：28

作者：

De Stefano, Nicola ^{[1
]}

Curtin, Francois ^{[2
,7
]}

Stubinski, Bettina ^{[2
,7
]}

Blevins, Gregg ^{[3
]}

Drulovic, Jelena ^{[4
]}

Issard, Delphine ^{[2
,7
]}

Shotekov, Penko ^{[5
]}

Gasperini, Claudio ^{[6
]}

机构：

[1] Univ Siena, Dept Neurol & Behav Sci, I-53100 Siena, Italy

[2] Merck Serono SA, Geneva, Switzerland

[3] Univ Alberta, Div Neurol, Edmonton, AB, Canada

[4] Univ Belgrade, Inst Neurol, Clin Ctr Serbia, Belgrade, Serbia

[5] UMBAL Alexandovska, Neurol Clin, Sofia, Bulgaria

[6] San Camillo Forlanini Hosp, Rome, Italy

[7] Merck KGaA, Darmstadt, Germany

来源：

MULTIPLE SCLEROSIS JOURNAL | 2010年 / 16卷 / 07期

关键词：

efficacy; interferon beta-1a; magnetic resonance imaging; randomized controlled trial; relapsing-remitting multiple sclerosis;

D O I：

10.1177/1352458510362442

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

w This study evaluated the efficacy of a new formulation of subcutaneous (sc) interferon (IFN)-beta 1a in relapsing-remitting multiple sclerosis (RRMS). Patients (n=180) were randomized (2:1) to IFN-beta 1a or placebo for 16 weeks; all patients then received IFN-beta 1a for 24 weeks. Monthly brain MRI was performed. At week 16, the mean number of combined unique active (CUA) lesions was lower with IFN-beta 1a than with placebo (p < 0.001; 69% fewer lesions). The mean cumulative number of CUA lesions was already lower with IFN-beta 1a by week 4 ( post hoc analysis; p=0.015). The new formulation of sc IFN-beta 1a has rapid beneficial effects on MRI outcomes in RRMS.

引用

页码：888 / 892

页数：5

共 50 条

[31] Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing-remitting multiple sclerosis: A retrospective analysis
Fisher, E.
Nakamura, K.
Lee, J-C
You, X.
Sperling, B.
Rudick, R. A.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (05) : 668 - 676
[32] Efficacy of a new formulation of subcutaneous interferon beta-1a in patients with relapsing-remitting multiple sclerosis: results at 16 weeks from a double-blind, placebo-controlled study
De Stefano, Nicola
[J]. MULTIPLE SCLEROSIS, 2008, 14 : S295 - S295
[33] Impact of daclizumab versus interferon beta-1a on patient-reported outcomes in relapsing-remitting multiple sclerosis
Liu, Ying
Vollmer, Timothy
Havrdova, Eva
Riester, Katherine
Lee, Andrew
Phillips, Glenn
Wang, Ping
Sabatella, Guido
[J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 11 : 18 - 24
[34] Influence of histocompatibility genes on the clinical course of patients with relapsing-remitting multiple sclerosis treated with interferon beta-1a
Fletcher, S.
Klein, T.
Pollak, L.
[J]. MULTIPLE SCLEROSIS, 2007, 13 : S200 - S201
[35] COST-UTILITY ANALYSIS OF ALEMTUZUMAB VERSUS SUBCUTANEOUS INTERFERON BETA-1A FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS: US PAYER PERSPECTIVE
Smith, A.
Hashemi, L.
Wandstrat, T.
[J]. VALUE IN HEALTH, 2017, 20 (05) : A193 - A193
[36] Health economic evaluation of interferon beta-1a versus interferon beta-1b for patients with relapsing-remitting multiple sclerosis in Switzerland
Nuijten, M. J. C.
Chofflon, M.
[J]. MULTIPLE SCLEROSIS, 2007, 13 : S262 - S262
[37] Alemtuzumab decreases new lesion formation and slows the rate of brain atrophy in relapsing-remitting Multiple sclerosis patients previously treated with subcutaneous interferon beta-1a
Barkhof, F.
Rovira, A.
Ziemssen, T.
Margolin, D. H.
Kasten, L.
Arnold, D. L.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 118 - 118
[38] Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis
Zhang, Jian
Shi, Shengliang
Zhang, Yueling
Luo, Jiefeng
Xiao, Yousheng
Meng, Lian
Yang, Xiaobo
[J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (11):
[39] Peginterferon Beta-1a: A Review of Its Use in Patients with Relapsing-Remitting Multiple Sclerosis
Sheridan M. Hoy
[J]. CNS Drugs, 2015, 29 : 171 - 179
[40] Peginterferon Beta-1a: A Review of Its Use in Patients with Relapsing-Remitting Multiple Sclerosis
Hoy, Sheridan M.
[J]. CNS DRUGS, 2015, 29 (02) : 171 - 179

← 1 2 3 4 5 →